Bruce A Larson
Overview
Explore the profile of Bruce A Larson including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
44
Citations
757
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Larson B, Tsikhutsu I, Bii M, Halim N, Agaba P, Sugut W, et al.
BMC Infect Dis
. 2023 Apr;
23(1):257.
PMID: 37098468
Background: This study evaluated the effect of revisions to existing peer-counselor services, called Mentor Mothers (MM), at maternal and child health clinics on medication adherence for women living with HIV...
2.
Tenforde M, Muthoga C, Ponatshego P, Ngidi J, Mine M, Greene G, et al.
Wellcome Open Res
. 2022 Jan;
6:55.
PMID: 35087954
Cryptococcal antigen (CrAg) screening in individuals with advanced HIV reduces cryptococcal meningitis (CM) cases and deaths. The World Health Organization recently recommended increasing screening thresholds from CD4 ≤100 cells/µL to...
3.
Rajasingham R, Nalintya E, Israelski D, Meya D, Larson B, Boulware D
Med Mycol
. 2022 Jan;
60(2).
PMID: 35026017
Lay Summary: We evaluate the efficacy necessary for AmBisome + fluconazole to be cost-effective to prevent cryptococcal meningitis. We found that if AmBisome pre-emptive therapy has an efficacy of 85%...
4.
Long L, Rosen S, Nichols B, Larson B, Ndlovu N, Meyer-Rath G
J Int AIDS Soc
. 2021 Jun;
24 Suppl 3:e25707.
PMID: 34189873
Introduction: In recent years, many countries have adopted evidence-based budgeting (EBB) to encourage the best use of limited and decreasing HIV resources. The lack of data and evidence for hard...
5.
Larson B, Pascoe S, Huber A, Long L, Murphy J, Miot J, et al.
PLoS One
. 2021 Mar;
16(3):e0248551.
PMID: 33735206
Introduction: In 2016, under its new National Adherence Guidelines (AGL), South Africa formalized an existing model of fast-track HIV treatment initiation counselling (FTIC). Rollout of the AGL included an evaluation...
6.
Brennan A, Maskew M, Larson B, Tsikhutsu I, Bii M, Vezi L, et al.
BMJ Open
. 2020 Sep;
10(9):e035794.
PMID: 32895266
Objective: We used screening data and routine clinic records for intervention arm patients in the Simplified Algorithm for Treatment Eligibility (SLATE) trials to describe the prevalence of tuberculosis (TB) symptoms,...
7.
Larson B, Pascoe S, Huber A, Long L, Murphy J, Miot J, et al.
J Int AIDS Soc
. 2020 Jul;
23(7):e25541.
PMID: 32686911
Introduction: South Africa's National Department of Health launched the National Adherence Guidelines for Chronic Diseases in 2015. These guidelines include adherence clubs (AC) and decentralized medication delivery (DMD) as two...
8.
Yukich J, Scott C, Silumbe K, Larson B, Bennett A, Finn T, et al.
Am J Trop Med Hyg
. 2020 Jul;
103(2_Suppl):46-53.
PMID: 32618249
Community-wide administration of antimalarial drugs in therapeutic doses is a potential tool to prevent malaria infection and reduce the malaria parasite reservoir. To measure the effectiveness and cost of using...
9.
Tenforde M, Muthoga C, Callaghan A, Ponetshego P, Ponatshego P, Ngidi J, et al.
Wellcome Open Res
. 2020 Mar;
4:144.
PMID: 31803848
Cryptococcal antigen (CrAg) screening for antiretroviral therapy (ART)-naïve adults with advanced HIV/AIDS can reduce the incidence of cryptococcal meningitis (CM) and all-cause mortality. We modeled the cost-effectiveness of laboratory-based "reflex"...
10.
Larson B, Halim N, Tsikhutsu I, Bii M, Coakley P, Rockers P
Glob Health Res Policy
. 2019 Oct;
4:29.
PMID: 31637308
Background: In the typical prevention of mother to child transmission (PMTCT) of HIV cascade of care discussion or analysis, the period of analysis begins at the first visit for antenatal...